Sign up for free insights newsletter
SD

Sandoz Group AG

SDZNYUnited States

Need professional-grade analysis? Visit stockanalysis.com

$75.99
-0.77%
End of day
Market Cap

$33.22B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

134.00%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-4.24-2.800.433.524.021.71
Calmar-26.89-4.100.483.524.190.09
Sharpe-6.40-1.650.242.082.440.77
Omega0.000.551.081.361.431.13
Martin-42.98-6.091.1612.0515.374.89
Ulcer1.8312.537.645.435.076.46

Sandoz Group AG (SDZNY) Price Performance

Sandoz Group AG (SDZNY) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $75.99, down 0.77% from the previous close.

Over the past year, SDZNY has traded between a low of $36.48 and a high of $93.35. The stock has gained 85.6% over this period. It is currently 18.6% below its 52-week high.

Sandoz Group AG has a market capitalization of $33.22B and a dividend yield of 134.00%.

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$11.16B
EBITDA
$1.89B
Profit Margin
8.19%
EPS (TTM)
2.09
Book Value
21.69

Technical Indicators

52 Week High
$94.15
52 Week Low
$34.97
50 Day MA
$81.08
200 Day MA
$66.93
Beta
0.33

Valuation

Trailing P/E
36.64
Forward P/E
16.89
Price/Sales
2.98
Price/Book
3.53
Enterprise Value
$37.10B